Henry Schein
Medical supplies distributor.
Based in NY
🤖
AI Overview
With $1.2M in lobbying spend across 22 quarterly filings, Henry Schein is a significant lobbying presence. They deploy 28 individual lobbyists Their lobbying covers 4 issue areas. Active from 2020 to 2025.
$1.2M
Total Spend
6
Years Active
1
Firms Hired
28
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $30K |
| 2021 | $320K |
| 2022 | $220K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
Dean RosenDavid ThomasElise Finley PickeringDavid CastagnettiBruce MehlmanSage EastmanLauren AronsonSteve HaroMichael RobinsonConstantine HingsonHelen TolarNichole DistefanoMckenzie BricePaul ThornellAlexander PerkinsStephen CoteVictoria FloodRosemary GutierrezZachary MalloveCaitlin Van SantLisa GoldmanAlyene MlinarErica ChabotAnnie WolfNaveen ParmarJon AdameJoseph BrownEarl Flood
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues, Medicare/Medicaid, Budget/Appropriations
- •Access to supplies, testing and vaccines for physician offices and health centers.
- •H.R. 1319 - American Rescue Plan Act of 2021; P.L. 117-2.
- •Issues related to COVID-19 vaccine distribution.
- •Issues related to COVID-19 vaccine distribution.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.